Back

Changing treatment paradigms in the management of chronic hyperkalaemia.

23 May 2016 (13:05 - 13:25)
Organised by:
Congress Presentation Part of: Hyperkalaemia: are your patients missing out? Chronic heart failure HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Matthew Weir

Baltimore (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor B. Pitt (Ann Arbor, US)
Presentation thumbnail
Hyperkalaemia: pathophysiology, clinical significance and unmet need.
Professor B. Williams (London, GB)
Presentation thumbnail
Are patients missing out? Will new therapy options lead to better heart failure management?
Professor C. Lam (Singapore, SG)
Presentation thumbnail
Summary and close.
Professor B. Pitt (Ann Arbor, US)

Access the full session

Session thumbnail
Hyperkalaemia: are your patients missing out?

The Event

Event poster

HEART FAILURE 2016

23 May 2016 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Challenges of managing hyperkalaemia in HF patients with CKD while maintaining RAAS inhibitor therapy
31 August 2024
thumbnail
Congress Presentation
Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF
29 August 2020
thumbnail
Congress Presentation
Potantial clinical application of potassium binders in patients with chronic heart failure in real life clinical practice: results from TREAT HF study
28 August 2020
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources